Gillespie Robinson & Grimm Lifted Its Cvs Health (CVS) Position; Shorts at INVICTUS MD STRATEGIES ORDINARY SH (IVITF) Raised By 60.87%

June 21, 2018 - By Dolores Ford

CVS Health Corporation (NYSE:CVS) Logo

Gillespie Robinson & Grimm Inc increased Cvs Health Corp (CVS) stake by 13.57% reported in 2018Q1 SEC filing. Gillespie Robinson & Grimm Inc acquired 41,176 shares as Cvs Health Corp (CVS)’s stock declined 3.22%. The Gillespie Robinson & Grimm Inc holds 344,582 shares with $21.44 million value, up from 303,406 last quarter. Cvs Health Corp now has $72.79 billion valuation. The stock increased 1.17% or $0.83 during the last trading session, reaching $71.6. About 9.28M shares traded or 6.64% up from the average. CVS Health Corporation (NYSE:CVS) has declined 13.06% since June 21, 2017 and is downtrending. It has underperformed by 25.63% the S&P500. Some Historical CVS News: ; 13/03/2018 – CVS: Aetna Transaction Expected to Close in Second Half of 2018; 18/04/2018 – Phoenix VA Health Care System, TriWest and CVS Health Mark First Anniversary of Program that Expands Veterans’ Access to Health Care; 02/05/2018 – CVS Health 1Q Rev $45.69B; 09/04/2018 – TABLE-CVS Bay 2687.T -2017/18 parent forecast; 14/03/2018 – CVS and Walgreens hope that by helping people pick up their prescriptions, they can boost the rates of people taking their drugs, improve patient outcomes and ultimately lower costs; 06/03/2018 – Read CVS Tea Leaves to See Flatter Treasury Curve: Markets Live; 11/04/2018 – CVS Launches Program Aimed At Tackling High Cost Of Medication — MarketWatch; 06/03/2018 – CVS Supersize $44B Bond for Aetna Deal Gets Triple Orders — Barron’s Blog; 22/03/2018 – CVS Health Receives NCQA Utilization Management Accreditation; 26/04/2018 – CVS Health Underscores Commitment to Safe Medication Disposal Ahead of National Prescription Drug Take-Back Day on April 28

INVICTUS MD STRATEGIES CORP ORDINARY SH (OTCMKTS:IVITF) had an increase of 60.87% in short interest. IVITF’s SI was 92,500 shares in June as released by FINRA. Its up 60.87% from 57,500 shares previously. With 283,400 avg volume, 0 days are for INVICTUS MD STRATEGIES CORP ORDINARY SH (OTCMKTS:IVITF)’s short sellers to cover IVITF’s short positions. The SI to INVICTUS MD STRATEGIES CORP ORDINARY SH’s float is 0.17%. The stock increased 3.15% or $0.04 during the last trading session, reaching $1.31. About shares traded. Invictus MD Strategies Corp. (OTCMKTS:IVITF) has 0.00% since June 21, 2017 and is . It has underperformed by 12.57% the S&P500.

Investors sentiment increased to 0.9 in Q1 2018. Its up 0.18, from 0.72 in 2017Q4. It increased, as 97 investors sold CVS shares while 512 reduced holdings. 117 funds opened positions while 431 raised stakes. 821.03 million shares or 0.67% more from 815.59 million shares in 2017Q4 were reported. Barclays Public Limited Com accumulated 2.93M shares. Gulf Savings Bank (Uk) reported 319,348 shares. 696,889 are held by Veritas Invest Mgmt Ltd Liability Partnership. Arizona State Retirement System holds 0.19% or 308,962 shares. Fayerweather Charles stated it has 2.74% of its portfolio in CVS Health Corporation (NYSE:CVS). Bnp Paribas Arbitrage has 0% invested in CVS Health Corporation (NYSE:CVS). Btc Capital Mngmt holds 0.87% of its portfolio in CVS Health Corporation (NYSE:CVS) for 85,931 shares. Taylor Asset Mngmt owns 0.23% invested in CVS Health Corporation (NYSE:CVS) for 7,700 shares. Northcoast Asset Mgmt Ltd Llc reported 33,484 shares. Texas-based St James Limited Liability Company has invested 5.88% in CVS Health Corporation (NYSE:CVS). Commerce Fincl Bank owns 76,411 shares. Todd Asset Ltd Limited Liability Company holds 185,703 shares or 0.32% of its portfolio. Cornerstone Advsrs Incorporated holds 0.4% or 54,000 shares in its portfolio. Hourglass Cap Ltd Liability invested 0.12% in CVS Health Corporation (NYSE:CVS). Verity And Verity Limited Liability accumulated 98,321 shares or 1.65% of the stock.

Among 26 analysts covering CVS Health (NYSE:CVS), 19 have Buy rating, 0 Sell and 7 Hold. Therefore 73% are positive. CVS Health had 77 analyst reports since July 22, 2015 according to SRatingsIntel. The stock of CVS Health Corporation (NYSE:CVS) has “Neutral” rating given on Thursday, December 17 by Goldman Sachs. The firm has “Neutral” rating given on Friday, November 3 by Citigroup. The rating was initiated by Barclays Capital on Friday, December 18 with “Overweight”. The firm has “Buy” rating by Leerink Swann given on Tuesday, April 10. SunTrust maintained CVS Health Corporation (NYSE:CVS) on Thursday, January 4 with “Buy” rating. The rating was maintained by Oppenheimer with “Buy” on Tuesday, August 8. The firm earned “Hold” rating on Friday, September 15 by Jefferies. As per Wednesday, August 16, the company rating was downgraded by Wolfe Research. The firm earned “Buy” rating on Thursday, February 8 by RBC Capital Markets. The rating was maintained by Bank of America with “Buy” on Wednesday, April 11.

More notable recent CVS Health Corporation (NYSE:CVS) news were published by: Seekingalpha.com which released: “CVS And Aetna Are Changing The Healthcare Paradigm” on June 18, 2018, also Fool.com with their article: “Why CVS Health, Foundation Medicine, and Solid Biosciences Jumped Today” published on June 19, 2018, Prnewswire.com published: “CVS Health Expands Safe Drug Disposal at CVS Pharmacy Locations in Arizona to Help Combat Opioid Abuse” on June 20, 2018. More interesting news about CVS Health Corporation (NYSE:CVS) were released by: Seekingalpha.com and their article: “5 Reasons Disney And Comcast Will Likely Crush The Market In The Future No Matter Who Buys Fox” published on June 20, 2018 as well as Streetinsider.com‘s news article titled: “AMA Comes Out Against CVS Health (CVS)/Aetna (AET) Merger” with publication date: June 19, 2018.

Since February 16, 2018, it had 2 insider buys, and 1 sale for $713,454 activity. DORMAN DAVID W had bought 24,300 shares worth $1.51 million. Foulkes Helena also sold $1.42M worth of CVS Health Corporation (NYSE:CVS) shares. BROWN C DAVID II bought $619,900 worth of stock or 10,000 shares.

Gillespie Robinson & Grimm Inc decreased Mettler (NYSE:MTD) stake by 3,166 shares to 21,923 valued at $12.61 million in 2018Q1. It also reduced Visa Inc (NYSE:V) stake by 8,545 shares and now owns 259,769 shares. Suntrust Banks (NYSE:STI) was reduced too.

CVS Health Corporation (NYSE:CVS) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


>